<DOC>
	<DOCNO>NCT00395824</DOCNO>
	<brief_summary>Hemodialysis cause contact activation coagulation pathway ( 1 ) . For reason , unfractionated low molecular weight heparin administer daily practice prevent thrombosis dialyzer blood circuit , dose commonly used cause systemic anticoagulation . This cause serious complication patient high risk bleeding . Regional low-dose heparinization , use prostacycline , regional citrate anticoagulation ( RCA ) , high-flow-rate hemodialysis without anticoagulation show reduce bleed complication . Each method , however , characterize technical difficulty , limitation , complication . The present study aim compare efficacy safety heparin-coated polyacrylonitrile membrane ( AN69ST ) regional citrate anticoagulation hemodialysis patient risk bleed</brief_summary>
	<brief_title>Citrate Anticoagulation vs. Heparin-Coated Dialyzers</brief_title>
	<detailed_description>1 . Open label single centre prospective randomize trial include 33 patient age 18 year chronic kidney disease stage 5 require intermittent hemodialysis University Hospital Leuven risk bleeding . Exclusion criterion : haemostatic disorder favour either bleed clotting , anti-vitamin K heparin treatment , heparin induce thrombocytopenia haemodynamic instability . Written inform consent enrolment . 2 . Random allocation ( seal enveloppe ) RCA calcium free dialysate ( RCA-Ca0 ) , RCA calcium contain dialysate ( RCA-Ca1,5 ) anticoagulant-free hemodiaysis heparin-coated polyacrylonitrile membrane ( Nephral 300STÂ® ) . 3 . At end dialysis session , arterial venous drip chamber filter inspect visible sign coagulation . Corresponding standard care dialysis unit , semi-quantitative score range 0 ( sign clot ) 4 ( complete occlusion ) use evaluation dialyzer . By definition , drip chamber consider clot thrombus visible rinse back procedure . A fibrin ring wall drip chamber consider normal . 4 . Blood sample assessment prothrombin fragment F1+2 d-dimers collect inlet blood catheter prior hemodialysis initiation hemodialysis T15 , T120 T238 .</detailed_description>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>age 18 year chronic kidney disease stage 5 require intermittent hemodialysis risk bleed write informed consent haemostatic disorder favour either bleed clot antivitamin K heparin treatment heparin induce thrombocytopenia haemodynamic instability</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>citrate</keyword>
	<keyword>anticoagulation</keyword>
	<keyword>heparin-coated membrane</keyword>
</DOC>